Rhumbline Advisers »

Design Therapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2024-03-31 $211k 53k 4.03
2023-12-31 $135k 51k 2.65
2023-09-30 $124k 53k 2.36
2023-06-30 $325k 52k 6.30
2023-03-31 $298k 52k 5.77
2022-12-31 $530k 52k 10.27
2022-09-30 $866k 52k 16.73
2022-06-30 $675k 48k 14.00
2022-03-31 $457k 28k 16.16
2021-12-31 $499k 23k 21.43
2021-09-30 $156k 11k 14.73